80 percent of cervical cancers found to be preventable with latest 9-valent HPV vaccine
The new 9-valent human papillomavirus vaccine, can potentially prevent 80 percent of cervical cancers in the United States, if given to all 11- or 12-year-old children before they are exposed to the virus. The study also found the 9-Valent vaccine, under the trademark of Gardasil-9, has the potential to protect against an additional 8 percent of oropharyngeal cancers, which include the base of the tongue and tonsils. This disease is the second-most-common HPV-associated cancer.
Source: ScienceDaily Headlines - Category: Science Source Type: news
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Cervical Cancer | Cervical Cancer Vaccine | Children | Gardasil | Genital Warts | Human Papillomavirus (HPV) | Oropharyngeal Cancer | Science | Study | Tonsillitis | Vaccines